Skip to main content
. 2016 Jul 4;6(7):e217. doi: 10.1038/nutd.2016.25

Figure 1.

Figure 1

Background OAD therapy across five regions at study entry by cohort (ITT population). Alpha GI, alpha-glucosidase inhibitors; ITT, intention-to-treat; Met, metformin; OAD, oral antidiabetes drugs; TZD, thiazolidinediones.